Eli Lilly and Co. told a federal jury that a German company is trying to take credit for centuries-old Chinese medicine in seeking royalties on the use of its erectile-dysfunction drug Cialis to treat an enlarged prostate.
News that federal regulators rejected Lilly’s drug for arthritis sent the stock tumbling more than 5 percent Monday, and sent surprised analysts searching for answers.
The drug, which has the proposed brand name Olumiant and is approved for use in Europe, was expected to be a big seller.
The money, provided to the workforce initiative Ascend Indiana, will train up to 50 specialists a year targeting Indiana's growing opioid epidemic.
The federal agency says the Indianapolis doctor studying Pfizer’s Chantix last year failed to keep accurate records and used patients who didn’t meet the trial requirements.
Broadening its efforts to defuse outrage over skyrocketing prices, the pharmaceutical industry’s lobbying association has started an advertising campaign urging insurers to share with customers more of the benefits of rebates they’ve negotiated.
The state Senate approved the measure Thursday by a 32-16 vote after lengthy discussion about needle exchanges, which aim to reduce the spread of infectious diseases by providing people with clean syringes and discouraging needle sharing
Almost half of graduating students in Marian University’s novice College of Osteopathic Medicine are choosing to serve residencies in family medicine.
In the latest sign of health care consolidation, Indiana’s largest independent physician group has agreed to be acquired by the nation’s largest health insurer for $184 million.
A sexual harassment scandal involving host Bill O’Reilly has prompted major advertisers such as Eli Lilly and Co. and several automakers to drop out. Indianapolis-based Angie’s List is among those sticking with the show.
Republicans entertained a fresh White House offer to revise the party's failed health care bill Tuesday as the GOP tried to resuscitate the measure that crashed less than two weeks ago.
Rainer Fischer’s goal is to spur collaboration in research and commercialization of life sciences products.
Two Indianapolis-based subsidiaries of Swiss pharmaceutical giant Roche Group are accusing a group of pharmacies and supply houses of engaging in an elaborate scheme to defraud Roche of millions of dollars worth of sales on diabetes test strips.
An Indiana Senate panel on Thursday advanced a two-year state budget plan with significant differences in funding for roads, entrepreneurship and education from the House’s plan.
The expansion at the Lilly Technology Center southwest of downtown is part of an $850 million investment the company is making this year in its U.S. research labs, manufacturing plants and other operations.
Lifestyle and heredity get the most blame for cancer, but new research suggests random chance plays a bigger role than people realize.
Republicans muscled their capstone health care overhaul past an initial barrier and toward a climactic roll call Friday, plunging ahead despite uncertainty over whether they had the votes to prevail.
The fate of the Republicans’ health care bill hangs in the balance, but Gov. Eric Holcomb is giving it his support.
Dave Ricks joined Lilly in 1996 and most recently served as president of Lilly Bio-Medicines. He took over as president and CEO on Jan. 1.
In hospitals and clinics around Indiana, specialized nurses with advanced degrees and extensive training are booming in numbers.
